In vitro methodologies to evaluate nanocarriers for cancer treatment: where are we? (2025)
- Authors:
- USP affiliated authors: LOPES, LUCIANA BIAGINI - ICB ; SALATA, GIOVANNA CASSONE - ICB ; HIROKAWA, CAMILA MEGUMI - ICB ; MELO, GIOVANNA BARROS DE - ICB ; MALAGÓ, ISABELLA DRASZESSKI - ICB ; NUNES, JÉSSICA RIBEIRO - ICB ; PASSOS, JULIA SAPIENZA - ICB ; DARÉ, REGINA GOMES - ICB
- Unidade: ICB
- DOI: 10.1186/s12645-025-00321-6
- Subjects: FARMACOLOGIA; CÉLULAS CULTIVADAS DE TUMOR; NANOPARTÍCULAS; ORGANELAS CELULARES; NANOCIÊNCIA; QUIMIOTERÁPICOS; CITOESQUELETO
- Keywords: NANOCARREADORES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Cancer Nanotechnology
- ISSN: 1868-6966
- Volume/Número/Paginação/Ano: v. 16, art. 21, 66 p., 2025
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc-nd
-
ABNT
SALATA, Giovanna Cassone et al. In vitro methodologies to evaluate nanocarriers for cancer treatment: where are we?. Cancer Nanotechnology, v. 16, p. 66 , 2025Tradução . . Disponível em: https://doi.org/10.1186/s12645-025-00321-6. Acesso em: 27 dez. 2025. -
APA
Salata, G. C., Hirokawa, C. M., Melo, G. B. de, Malagó, I. D., Nunes, J. R., Passos, J. S., et al. (2025). In vitro methodologies to evaluate nanocarriers for cancer treatment: where are we? Cancer Nanotechnology, 16, 66 . doi:10.1186/s12645-025-00321-6 -
NLM
Salata GC, Hirokawa CM, Melo GB de, Malagó ID, Nunes JR, Passos JS, Daré RG, Lopes LB. In vitro methodologies to evaluate nanocarriers for cancer treatment: where are we? [Internet]. Cancer Nanotechnology. 2025 ; 16 66 .[citado 2025 dez. 27 ] Available from: https://doi.org/10.1186/s12645-025-00321-6 -
Vancouver
Salata GC, Hirokawa CM, Melo GB de, Malagó ID, Nunes JR, Passos JS, Daré RG, Lopes LB. In vitro methodologies to evaluate nanocarriers for cancer treatment: where are we? [Internet]. Cancer Nanotechnology. 2025 ; 16 66 .[citado 2025 dez. 27 ] Available from: https://doi.org/10.1186/s12645-025-00321-6 - Evaluation of polyelectrolyte nanoparticles of chitosan and hyaluronic acid as topical delivery systems for cytotoxic agents
- A lipid-based in situ-forming hexagonal phase for prolonged retention and drug release in the breast tissue
- Molecular effects of paclitaxel-elacridar nanoemulsions in breast cancer cells: impact on uptake, cell cycle and signaling pathways
- Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer
- Nanoemulsions for topical-transdermal administration of a retinoid: understanding the effects of oil phase and terpene concentration on nanoemulsion characteristics, irritation potential, skin penetration and cytotoxicity
- Simvastatin and adenosine-co-loaded nanostructured lipid carriers for wound healing: development, characterization and cell-based investigation
- Phosphatidylcholine-based nanoemulsions for paclitaxel and a P-Glycoprotein inhibitor delivery and breast cancer intraductal treatment
- Rethinking breast cancer chemoprevention: technological advantages and enhanced performance of a Nanoethosomal-Based Hydrogel for topical administration of Fenretinide
- Monoolein-based nanodispersions for cutaneous co-delivery of methylene blue and metformin: thermal and structural characterization and effects on the cutaneous barrier, skin penetration and cytotoxicity
- Optimization of nanoemulsified systems containing lamellar phases for co-delivery of celecoxib and endoxifen to the skin aiming for breast cancer chemoprevention and treatment
Informações sobre o DOI: 10.1186/s12645-025-00321-6 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
In_vitro_methodologies_to... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
